Skip to main content
TipRanks
Go Ultimate75% OFF
Third Arc Bio Inc logo

Third Arc Bio Inc: Valuation, Funding & Investors

Philadelphia, Pennsylvania 19002, UShttps://thirdarcbio.com/Therapeutics

Third Arc Bio Inc. is a clinical-stage biotechnology company developing novel multifunctional antibodies for a range of oncology and immunology & inflammation (I&I) indications. The company focuses on designing antibody therapeutics to address diverse tumor and immune-mediated disease mechanisms and is advancing a pipeline of clinical-stage candidates.

Leadership & Board

Current Number of Employees
41
Current LinkedIn Followers
3,928

Latest Estimated Valuation

Total Amount Raised
$52M
Total Funding Rounds
1
Latest Funding Amount
$52M
Latest Funding Round
Series A

Employee Trend

Third Arc Bio Inc had 41 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

41Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Apr 27, 2026May 11, 2026May 25, 2026Jun 08, 2026Jun 22, 2026Jul 06, 2026Jul 27, 2026Aug 10, 2026Aug 24, 2026Sep 07, 2026Sep 21, 2026Oct 05, 2026Oct 19, 2026Nov 02, 2026Nov 16, 2026

Social Trend

Third Arc Bio Inc had 3,928 followers as of November 16, 2026. The number of followers increased by 4 (0.10%) week-over-week.

3,928Latest Followers Count
4(0.10%)Week-Over-Week Change
01,0002,0003,0004,000Apr 27, 2026May 11, 2026May 25, 2026Jun 08, 2026Jun 22, 2026Jul 06, 2026Jul 27, 2026Aug 10, 2026Aug 24, 2026Sep 07, 2026Sep 21, 2026Oct 05, 2026Oct 19, 2026Nov 02, 2026Nov 16, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Feb 04, 2026Series A$52.00M―

Similar Companies

A snapshot of private companies similar to Third Arc Bio Inc, helping you discover and navigate related company profiles.

Related News and Analysis